Asthma and Obesity: Pilot Study
Obesity and Asthma: Unveiling Metabolic and Behavioral Pathways
2 other identifiers
interventional
27
1 country
2
Brief Summary
Develop and pilot test four theory-based educational modules that integrate counseling for asthma and obesity to promote greater physical activity among people with asthma.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable asthma
Started Oct 2019
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 1, 2019
CompletedFirst Posted
Study publicly available on registry
October 3, 2019
CompletedStudy Start
First participant enrolled
October 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedResults Posted
Study results publicly available
November 14, 2022
CompletedNovember 14, 2022
October 1, 2022
1.9 years
October 1, 2019
August 30, 2022
October 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Beliefs About Illness Perception Questionnaire (BIPQ)
BIPQ includes 5 cognitive domains (Identity, Cause, Timeline, Consequences, and Cure-Control) designed to rapidly assess the cognitive and emotional representations of illness. Each item in each domain is scored on a 0 (none) to 10 (extreme). Full scale from 0-80, where higher score reflects a more threatening view of the illness.
At 30 days Post-pilot follow-up visit, up to 2 months
Secondary Outcomes (6)
Medication Adherence Rating Scale (MARS)
At 30 days Post-pilot follow-up visit, up to 2 months
Physical Activity - Step Counts Per Day
Week 2, Week 4, and at 30 days Post-pilot follow-up visit
Time in Physical Activity
Week 2, Week 4, and at 30 days Post-pilot follow-up visit
Asthma Control Questionnaire (ACQ)
at 30 days Post-pilot follow-up visit, up to 2 months
Asthma Quality of Life Questionnaire (AQLQ)
at 30 days post-pilot follow-up visit, up to 2 months
- +1 more secondary outcomes
Study Arms (2)
Asthma and Exercise Lifestyle Change
EXPERIMENTALParticipants receive asthma and lifestyle change education related to exercise
Asthma Education
PLACEBO COMPARATORNo lifestyle change education
Interventions
Participants in the asthma and exercise lifestyle change arm will participate in 4 sessions focused on behavioral change and goal-setting education to teach them how to better incorporate exercise into their daily lives and better manage their asthma. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.
General asthma education, but no discussion of the role of exercise and other lifestyle habits in asthma self-management. Following sessions 1 and 4, these participants will use the accelerometer to track activity, but will be blinded to the data.
Eligibility Criteria
You may qualify if:
- years of age
- BMI ≥ 30
- Asthma diagnosis made by a health care provider
- Poor Asthma Control (ACQ score ≥ 0.75)
- English speaking
You may not qualify if:
- BMI \< 30
- Good asthma control (ACQ score \<0.75)
- Diagnosis of dementia
- Diagnosis of chronic obstructive pulmonary disease (COPD) or other chronic respiratory illness
- Smoking history of ≥15 pack-years owing to possible undiagnosed COPD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Colorado Denver, Anschutz Medical Campus
Aurora, Colorado, 80045, United States
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Juan P. Wisnivesky, MD, DrPH
- Organization
- Icahn School of Medicine at Mount Sinai
Study Officials
- PRINCIPAL INVESTIGATOR
Juan P. Wisnivesky, MD, DrPH
Icahn School of Medicine at Mount Sinai
- PRINCIPAL INVESTIGATOR
Alex D. Federman, MD, MPH
Icahn School of Medicine at Mount Sinai
- PRINCIPAL INVESTIGATOR
Fernando Holguin, MD, MPH
University of Colorado Denver, Anschutz Medical Campus
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The Research Coordinator who is administering the follow-up survey will be masked
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 1, 2019
First Posted
October 3, 2019
Study Start
October 3, 2019
Primary Completion
August 30, 2021
Study Completion
August 30, 2021
Last Updated
November 14, 2022
Results First Posted
November 14, 2022
Record last verified: 2022-10